Literature DB >> 18760175

Endoscopic papillary balloon dilation for the management of bile duct stones in patients 85 years of age and older.

Yukiko Ito1, Takeshi Tsujino, Osamu Togawa, Natsuyo Yamamoto, Hiroyuki Isayama, Ryo Nakata, Takao Kawabe, Masao Omata.   

Abstract

BACKGROUND: Endoscopic papillary balloon dilation (EPBD) is a possible alternative to endoscopic sphincterotomy for the treatment of bile duct stones. However, little information is available in the elderly.
OBJECTIVE: Our purpose was to evaluate the safety and efficacy of EPBD for bile duct stones in patients of 85 years of age and older.
DESIGN: Retrospective study from a single center.
SETTING: Tertiary care facility with experience in bile duct stone removal with EPBD. PATIENTS: A total of 406 patients (74 patients >/=85 years old, group A; 332 patients <85 years old, group B) with bile duct stones underwent EPBD. MAIN OUTCOME MEASUREMENTS: Efficacy and safety of EPBD between the 2 groups. Baseline patient characteristics were also evaluated.
RESULTS: The mean American Society of Anesthesiologists score in group A was significantly higher compared with that in group B (2.4 [0.5] vs 1.9 [0.7], P < .0001). Patients received anticoagulants more frequently and had larger and more numerous stones in group A than in group B with significant differences. Overall, bile duct clearance rates were similar in the 2 groups (91% vs 95%), but the mean number of sessions required for complete stone removal was significantly higher in group A (1.6 vs 1.4, P = .0081). The incidence of overall early complications after EPBD was lower in group A than in group B (2.7% vs 8.4%) but was not statistically different. None of the patients in group A had post-EPBD pancreatitis, whereas pancreatitis occurred in 5.7% in group B (P = .036). Bleeding was not observed after EPBD in 406 patients, including 7 patients in group A who received anticoagulation therapy at the time of EPBD. There was no significant difference in the cumulative stone nonrecurrence rate between group A and group B (log-rank test, P = .6225).
CONCLUSIONS: EPBD is a safe and effective technique for the treatment of bile duct stones even in high-risk elderly patients without an increased risk of pancreatitis and bleeding. Because the evaluation of outcomes might be biased by our study design (an open study), further studies are needed.

Entities:  

Mesh:

Year:  2008        PMID: 18760175     DOI: 10.1016/j.gie.2007.10.066

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  14 in total

Review 1.  Management of suspected stones in the common bile duct.

Authors:  Majid A Almadi; Jeffrey S Barkun; Alan N Barkun
Journal:  CMAJ       Date:  2012-04-16       Impact factor: 8.262

2.  Endoscopic papillary large balloon dilation for bile duct stones in elderly patients.

Authors:  Yuji Sakai; Toshio Tsuyuguchi; Harutoshi Sugiyama; Reina Sasaki; Dai Sakamoto; Masato Nakamura; Yuuto Watanabe; Takao Nishikawa; Shin Yasui; Rintaro Mikata; Osamu Yokosuka
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

3.  Efficacy and safety of endoscopic procedures for common bile duct stones in patients aged 85 years or older: A retrospective study.

Authors:  Tomoya Iida; Hiroyuki Kaneto; Kohei Wagatsuma; Hajime Sasaki; Yumiko Naganawa; Suguru Nakagaki; Shuji Satoh; Haruo Shimizu; Hiroshi Nakase
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

4.  Laparoscopic common bile duct exploration for elderly patients with choledocholithiasis: a systematic review and meta-analysis.

Authors:  Jisheng Zhu; Shuju Tu; Zhengjiang Yang; Xiaowei Fu; Yong Li; Weidong Xiao
Journal:  Surg Endosc       Date:  2020-02-03       Impact factor: 4.584

5.  Endoscopic papillary balloon dilation for bile duct stone removal in patients 60 years old or younger.

Authors:  Takeshi Tsujino; Haruhiko Yoshida; Hiroyuki Isayama; Yukiko Ito; Yoko Yashima; Hiroshi Yagioka; Hirofumi Kogure; Takashi Sasaki; Toshihiko Arizumi; Osamu Togawa; Saburo Matsubara; Yousuke Nakai; Naoki Sasahira; Kenji Hirano; Minoru Tada; Takao Kawabe; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2010-05-14       Impact factor: 7.527

6.  Endoscopic papillary balloon dilation for removal of choledocholithiasis: indications, advantages, complications, and long-term follow-up results.

Authors:  Joo Won Chung; Jae Bock Chung
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

7.  Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis.

Authors:  Naminatsu Takahara; Hiroyuki Isayama; Takashi Sasaki; Takeshi Tsujino; Nobuo Toda; Naoki Sasahira; Suguru Mizuno; Kazumichi Kawakubo; Hirofumi Kogure; Natsuyo Yamamoto; Yousuke Nakai; Kenji Hirano; Minoru Tada; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-02-22       Impact factor: 7.527

Review 8.  Balloon dilation itself may not be a major determinant of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Sung Ill Jang; Gak Won Yun; Dong Ki Lee
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Intraprocedural quality in endoscopic retrograde cholangiopancreatography: a meta-analysis.

Authors:  Anthony T DeBenedet; B Joseph Elmunzer; Sean T McCarthy; Grace H Elta; Philip S Schoenfeld
Journal:  Am J Gastroenterol       Date:  2013-07-23       Impact factor: 10.864

Review 10.  Diagnosis and management of choledocholithiasis in the golden age of imaging, endoscopy and laparoscopy.

Authors:  Renato Costi; Alessandro Gnocchi; Francesco Di Mario; Leopoldo Sarli
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.